Breakthrough Cancer Research: Weizmann University, Israel
A breakthrough cancer study in which patients suffering from a form of leukemia saw their diseases go into remission after they were treated with genetically modified T-cells has deep roots in Israel. One of the first in the world to work on the innovative cancer treatment technique, known as adaptive immunotherapy, was Professor Zelig Eshhar from Weizmann University in Israel. Last Tuesday, this technique was hailed worldwide as a potentially “extraordinary” development. Esh